AI platform co-founder: building the ‘holy grail’ for chemical patents

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

AI platform co-founder: building the ‘holy grail’ for chemical patents

5mins.jpg

Tamar Gomez, our latest ‘Five minutes with’ subject, discusses Markush formula descriptions, spinning plates and why her role is both exhilarating and terrifying

Welcome to the latest instalment of Managing IP’s ‘Five minutes with’ series, where we learn more about intellectual property practitioners on a personal and professional level. This time, we meet Tamar Gomez at Ankar AI, an artificial intelligence platform for inventors.

Someone asks you at a party what you do for a living. What do you say?

I help inventors create the ideas that solve the world’s toughest challenges

Talk us through a typical working day.

Wake up, coffee, run – that’s the calm. Then comes the storm: patents, AI, customers and a dash of chaos. Wouldn’t have it any other way.

What are you working on at the moment?

Right now, I’m working with chemists and drafters to build an AI assistant that writes crystal-clear Markush formula descriptions – the holy grail for chemical patents.

Does one big piece of work usually take priority or are you juggling multiple things?

As a founder, I’m always spinning plates: hiring brilliant people, talking to customers, and pushing the product forward. It’s a juggling act, and honestly, I love it.

What is the most exciting aspect of your role and what is the most stressful?

They’re the same: building the next generation of tools for inventors. It’s exhilarating and terrifying in equal measure.

Tell us the key characteristics that make a successful IP lawyer/practitioner.

I’m not an IP lawyer myself, but the best I’ve seen combine big-picture strategy with an obsession for detail. It’s a rare and powerful mix.

What is the most common misconception about IP?

That it’s niche! In reality, IP is how society values ideas. Without it, innovation would grind to a halt.

What or who inspires you?

My cofounder, Wiem Gharbi, inspires me daily – she’s unstoppable. And our team at Ankar: fiercely clever, endlessly resilient, never backing down.

If you weren’t in IP, what would you be doing?

I would be a soldier.

Any advice you would give your younger self?

You’ll figure it out

What is your motto in life?

À la vie, à la mort!

To find out more about Ankar AI, visit its website.

more from across site and SHARED ros bottom lb

More from across our site

Partners Alex Wilson and Andreas Kramer say bigger law firm rivals don’t necessarily gain by having a wider jurisdictional reach
VO, which has offices in the Netherlands, Belgium and Germany, is the second European IP firm to secure external backing this week
The Bardehle Pagenberg attorneys-at-law discuss the firm’s Managing IP EMEA Awards 2026 success, Unified Patent Court litigation strategy, and evolving European patent trends
A patent battle between two legal tech companies and a loss for Elon Musk’s xAI against OpenAI were also among the top talking points
With drug prices a hot topic in the US, courts are seemingly more reluctant to prevent the entry of generics to the market
Academic Eden Sarid joins us during Pride Month to discuss queer expression and IP law, Patagonia v Pattie Gonia, and how queer and AI-generated creations both pose novelty concerns
Patent attorney Michael Henson joins the firm to lead its freshly launched blockchain and digital assets practice
A dispute over mammogram technology, and a development in the case between GSK and Moderna were also among the top talking points in recent weeks
With rankings for Western Europe set to be published on June 25, we sat down with our research lead to find out what practitioners and law firms can expect
Peter O’Sullivan, a professional services executive, says he is looking forward to helping Pearce IP become the leading life sciences firm in Australia and New Zealand
Gift this article